Clinical Trials Logo

Clinical Trial Summary

The objectives of this study are to (1) test the feasibility of the clinical implementation of preemptive pharmacogenetic (PGx) testing in the emergency department (ED) and (2) determine if PGx testing (with appropriate decision support) decreases ED return visits and hospitalizations. We will conduct a randomized, controlled, pragmatic clinical trial assessing both the real-world effectiveness as well as implementation outcomes using a targeted PGx testing panel in several UF Health EDs.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06448091
Study type Interventional
Source University of Florida
Contact
Status Not yet recruiting
Phase N/A
Start date September 1, 2024
Completion date July 1, 2027